Urgent.News

What's breaking now, across thousands of outlets.

AI

Eli Lilly to Offer Early Access to Next-Gen Obesity Drug to Some Patients

Eli Lilly said on Monday it would allow a limited number of patients to have early access to its experimental obesity drug, retatrutide, before its US FDA approval.

Eli Lilly to Offer Early Access to Next-Gen Obesity Drug to Some Patients

We haven't written up this one. Business of Fashion has the full story — the link below goes straight to it.

Read the original at businessoffashion.com →

More in AI

Study finds Botox cuts pediatric chronic migraine headaches

A prospective study led by researchers at Children's National found that onabotulinumtoxinA (ONA), commonly known as Botox, reduces headache frequency and headache-related disability in children and young adults with chronic migraine, providing important evidence to support its use in a pediatric population where treatment options remain…

More from Tuesday 4 August →